--The Japanese government is in talks to procure Merck & Co.'s potential Covid-19 drug as soon as the end of the year, Japanese business daily Nikkei reported Sunday without citing sources.

--If the drug is approved in the U.S. and an application is made in Japan, the country's health ministry would consider approving the drug through an expedited process, the Nikkei report said.

Full story: https://s.nikkei.com/3Bk4rfm (Japanese)

Write to Kosaku Narioka at kosaku.narioka@wsj.com

(END) Dow Jones Newswires

October 03, 2021 22:48 ET (02:48 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Merck.
Merck (NYSE:MRK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Merck.